Research Site 10001-122 — Binghamton, New York

Research Site 10001-122 is a clinical research site located in Binghamton, New York, United States 13901.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 10001-122 has participated in 2 clinical trials.

Therapeutic areas: ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia.

Sponsors: The Medicines Company, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Binghamton

Browse all research sites in New York · View every site in Binghamton

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 10001-122?

Research Site 10001-122 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 10001-122 conducted?

Research Site 10001-122 has 2 clinical trials on record. Their work covers ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia.

Is Research Site 10001-122 accredited by Crixeo Clinical Trials?

Research Site 10001-122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 10001-122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.